| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.525 | 0.005 | 0.525 | Insulin secretagoues | 0.374 0.007 DBMET00294 0.211 0.031 DBMET00338 | ||
| 0.327 | 0.036 | 0.327 | Interleukin agonist | 0.246 0.082 DBMET00294 0.229 0.095 DBMET00338 | ||
| 0.348 | 0.088 | 0.348 | Antiobesity | 0.23 0.176 DBMET00294 | ||
| 0.328 | 0.075 | 0.332 | Cholesterol antagonist | 0.332 0.073 DBMET00294 0.306 0.087 DBMET00338 | DBMET00294 | |
| 0.321 | 0.072 | 0.321 | Calcium channel activator | 0.229 0.173 DBMET00294 0.237 0.162 DBMET00338 | ||
| 0.263 | 0.044 | 0.263 | Neuropeptide Y2 antagonist | |||
| 0.293 | 0.079 | 0.305 | Interleukin 2 agonist | 0.305 0.07 DBMET00294 0.285 0.085 DBMET00338 | DBMET00294 | |
| 0.339 | 0.126 | 0.352 | Calcium channel L-type activator | 0.231 0.228 DBMET00294 0.352 0.116 DBMET00338 | DBMET00338 | |
| 0.296 | 0.09 | 0.296 | Antithrombotic | 0.192 0.187 DBMET00294 | ||
| 0.276 | 0.074 | 0.276 | Insulysin inhibitor | |||
| 0.333 | 0.131 | 0.422 | 5 Hydroxytryptamine release inhibitor | 0.245 0.235 DBMET00294 0.422 0.065 DBMET00338 | DBMET00338 | |
| 0.263 | 0.065 | 0.263 | Gastrin inhibitor | 0.242 0.088 DBMET00338 | ||
| 0.268 | 0.083 | 0.268 | Spasmolytic | 0.22 0.105 DBMET00294 | ||
| 0.264 | 0.08 | 0.264 | Ca(v)3.3 blocker | |||
| 0.255 | 0.074 | 0.255 | Hypoglycemic | 0.231 0.089 DBMET00294 0.181 0.133 DBMET00338 | ||
| 0.256 | 0.079 | 0.256 | Transcription factor STAT3 inhibitor | |||
| 0.319 | 0.146 | 0.319 | Cyclophilin D inhibitor | 0.291 0.17 DBMET00294 | ||
| 0.199 | 0.035 | 0.199 | Neurotensin receptor agonist | 0.179 0.051 DBMET00338 | ||
| 0.219 | 0.056 | 0.23 | Insulin sensitizer | 0.167 0.11 DBMET00294 0.23 0.047 DBMET00338 | DBMET00338 | |
| 0.205 | 0.042 | 0.205 | Diuretic | |||
| 0.269 | 0.108 | 0.299 | Sodium/bile acid cotransporter inhibitor | 0.299 0.08 DBMET00294 0.259 0.119 DBMET00338 | DBMET00294 | |
| 0.171 | 0.017 | 0.171 | Caspase 3 inhibitor | 0.112 0.072 DBMET00338 | ||
| 0.266 | 0.112 | 0.266 | Apoptosis antagonist | 0.213 0.163 DBMET00294 0.216 0.16 DBMET00338 | ||
| 0.155 | 0.008 | 0.155 | Prostaglandin E2 antagonist | 0.078 0.02 DBMET00294 0.112 0.013 DBMET00338 | ||
| 0.183 | 0.037 | 0.196 | Anesthetic local | 0.096 0.086 DBMET00294 0.196 0.033 DBMET00338 | DBMET00338 | |
| 0.188 | 0.044 | 0.188 | Thiol protease inhibitor | |||
| 0.23 | 0.09 | 0.23 | Tyrosine 3 hydroxylase inhibitor | 0.229 0.092 DBMET00338 | ||
| 0.144 | 0.006 | 0.144 | Neuraminidase inhibitor | 0.113 0.011 DBMET00294 0.131 0.008 DBMET00338 | ||
| 0.271 | 0.134 | 0.271 | Calpain 2 inhibitor | |||
| 0.161 | 0.039 | 0.171 | Cyclooxygenase 3 inhibitor | 0.127 0.07 DBMET00294 0.171 0.033 DBMET00338 | DBMET00338 | |
| 0.227 | 0.105 | 0.227 | Transcription factor STAT inhibitor | |||
| 0.129 | 0.01 | 0.129 | Neuraminidase (influenza) inhibitor | 0.096 0.018 DBMET00294 0.117 0.012 DBMET00338 | ||
| 0.263 | 0.146 | 0.398 | Histamine release inhibitor | 0.202 0.2 DBMET00294 0.398 0.077 DBMET00338 | DBMET00338 | |
| 0.157 | 0.043 | 0.157 | Cell adhesion inhibitor | |||
| 0.173 | 0.06 | 0.173 | Protein-tyrosine phosphatase inhibitor | 0.152 0.076 DBMET00338 | ||
| 0.203 | 0.098 | 0.203 | Platelet antagonist | |||
| 0.165 | 0.062 | 0.168 | Phospholipase A2 inhibitor | 0.168 0.061 DBMET00338 | DBMET00338 | |
| 0.149 | 0.066 | 0.149 | Neuropeptide Y1 antagonist | |||
| 0.09 | 0.01 | 0.09 | Melanocortin 4 antagonist | 0.063 0.018 DBMET00294 | ||
| 0.195 | 0.118 | 0.195 | Calpain inhibitor | |||
| 0.131 | 0.057 | 0.131 | Proteasome inhibitor | |||
| 0.169 | 0.095 | 0.241 | Anesthetic general | 0.178 0.088 DBMET00294 0.241 0.054 DBMET00338 | DBMET00338 | |
| 0.104 | 0.032 | 0.104 | Cell adhesion molecule inhibitor | |||
| 0.151 | 0.079 | 0.151 | Anticoagulant | |||
| 0.134 | 0.062 | 0.134 | Antibacterial (Helicobacter pylori) | |||
| 0.252 | 0.181 | 0.252 | Analgesic | |||
| 0.081 | 0.014 | 0.081 | Melanocortin antagonist | 0.056 0.024 DBMET00294 | ||
| 0.072 | 0.006 | 0.072 | Neuraminidase (Influenza A) inhibitor | 0.056 0.017 DBMET00294 0.064 0.01 DBMET00338 | ||
| 0.073 | 0.013 | 0.083 | Adenine nucleotide translocase inhibitor | 0.07 0.015 DBMET00294 0.083 0.008 DBMET00338 | DBMET00338 | |
| 0.066 | 0.008 | 0.066 | Prostaglandin EP3 antagonist | 0.036 0.017 DBMET00294 0.045 0.011 DBMET00338 | ||
| 0.088 | 0.04 | 0.088 | Ca(v)3.1 blocker | |||
| 0.136 | 0.088 | 0.14 | Sphingosine 1-phosphate receptor 5 antagonist | 0.14 0.08 DBMET00338 | DBMET00338 | |
| 0.124 | 0.078 | 0.124 | Vanilloid 1 agonist | |||
| 0.098 | 0.06 | 0.098 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.066 | 0.028 | 0.066 | Prostaglandin antagonist | |||
| 0.12 | 0.086 | 0.127 | Interleukin 4 antagonist | 0.127 0.076 DBMET00294 0.116 0.091 DBMET00338 | DBMET00294 | |
| 0.086 | 0.053 | 0.086 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.145 | 0.113 | 0.225 | Lipocortins synthesis antagonist | 0.188 0.065 DBMET00294 0.225 0.043 DBMET00338 | DBMET00338 | |
| 0.071 | 0.04 | 0.071 | Potassium channel (ATP-sensitive) blocker | |||
| 0.13 | 0.1 | 0.13 | Thrombolytic | 0.118 0.113 DBMET00294 | ||
| 0.102 | 0.076 | 0.102 | Protein-tyrosine phosphatase 1B inhibitor | 0.1 0.078 DBMET00338 | ||
| 0.048 | 0.022 | 0.048 | GHS receptor agonist | |||
| 0.204 | 0.179 | 0.204 | Vasodilator, coronary | |||
| 0.111 | 0.088 | 0.111 | Toll-Like receptor 2 antagonist | |||
| 0.036 | 0.012 | 0.036 | Prostaglandin EP4 antagonist | |||
| 0.028 | 0.005 | 0.029 | Neuraminidase (Influenza B) inhibitor | 0.029 0.005 DBMET00338 | DBMET00338 | |
| 0.115 | 0.093 | 0.115 | Calcium channel blocker | |||
| 0.137 | 0.117 | 0.151 | Amyloid beta precursor protein antagonist | 0.151 0.1 DBMET00338 | DBMET00338 | |
| 0.109 | 0.09 | 0.112 | M17 leucyl aminopeptidase inhibitor | 0.112 0.085 DBMET00338 | DBMET00338 | |
| 0.171 | 0.153 | 0.241 | Superoxide dismutase inhibitor | 0.241 0.08 DBMET00338 | DBMET00338 | |
| 0.1 | 0.084 | 0.1 | Calcium channel (voltage-sensitive) blocker | |||
| 0.054 | 0.039 | 0.054 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.036 | 0.023 | 0.036 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.081 | 0.068 | 0.081 | Vanilloid agonist | |||
| 0.031 | 0.02 | 0.031 | Potassium channel subfamily K member 3 blocker | |||
| 0.068 | 0.056 | 0.071 | Aminopeptidase I inhibitor | 0.071 0.053 DBMET00338 | DBMET00338 | |
| 0.059 | 0.048 | 0.059 | Prostaglandin F2 alpha antagonist | 0.056 0.054 DBMET00294 | ||
| 0.053 | 0.042 | 0.053 | DNA helicase inhibitor | |||
| 0.04 | 0.031 | 0.04 | Integrin antagonist | |||
| 0.027 | 0.018 | 0.027 | Urotensin II agonist | |||
| 0.04 | 0.031 | 0.04 | Acetyl-CoA carboxylase inhibitor | |||
| 0.06 | 0.052 | 0.06 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.086 | 0.078 | 0.086 | Protease inhibitor | |||
| 0.067 | 0.061 | 0.074 | Peroxisome proliferator-activated receptor gamma antagonist | 0.074 0.044 DBMET00338 | DBMET00338 | |
| 0.014 | 0.01 | 0.014 | Integrin beta6 antagonist | |||
| 0.191 | 0.187 | 0.191 | Vasodilator, peripheral | |||
| 0.103 | 0.101 | 0.103 | Cathepsin H inhibitor | |||
| 0.071 | 0.069 | 0.071 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.016 | 0.015 | 0.016 | Tryptophan hydroxylase 1 inhibitor | |||
| 0.081 | 0.083 | 0.094 | ABCA1 expression enhancer | 0.094 0.059 DBMET00338 | DBMET00338 | |
| 0.032 | 0.035 | 0.053 | Factor VIIa inhibitor | 0.053 0.019 DBMET00338 | DBMET00338 | |
| 0.046 | 0.049 | 0.048 | Factor III inhibitor | 0.048 0.04 DBMET00338 | DBMET00338 | |
| 0.076 | 0.082 | 0.104 | Estrogen-related receptor beta agonist | 0.104 0.021 DBMET00338 | DBMET00338 | |
| 0.077 | 0.086 | 0.122 | Aminopeptidase B inhibitor | 0.122 0.052 DBMET00338 | DBMET00338 | |
| 0.05 | 0.061 | 0.054 | Immunoglobulin Fc receptor antagonist | 0.054 0.043 DBMET00338 | DBMET00338 | |
| 0.057 | 0.069 | 0.076 | Catalase inhibitor | 0.076 0.05 DBMET00338 | DBMET00338 | |
| 0.136 | 0.153 | 0.206 | Hypolipemic | 0.206 0.09 DBMET00338 | DBMET00338 | |
| 0.027 | 0.045 | 0.043 | Glutamate (mGluR3) agonist | 0.043 0.007 DBMET00338 | DBMET00338 | |
| 0.126 | 0.158 | 0.142 | P-glycoprotein inhibitor | 0.142 0.13 DBMET00294 | DBMET00294 | |
| 0.027 | 0.066 | 0.033 | Glutamate (mGluR8) antagonist | 0.033 0.032 DBMET00338 | DBMET00338 | |
| 0.076 | 0.117 | 0.182 | Carbonic anhydrase XV inhibitor | 0.182 0.022 DBMET00338 | DBMET00338 | |
| 0.178 | 0.22 | 0.215 | Immunosuppressant | 0.215 0.182 DBMET00294 | DBMET00294 | |
| 0.107 | 0.153 | 0.221 | Angiogenesis stimulant | 0.157 0.118 DBMET00294 0.221 0.084 DBMET00338 | DBMET00338 | |
| 0.016 | 0.082 | 0.038 | Kainate receptor antagonist | 0.038 0.03 DBMET00338 | DBMET00338 | |
| 0.029 | 0.117 | 0.05 | Leukotriene B4 antagonist | 0.05 0.045 DBMET00338 | DBMET00338 | |
| 0.064 | 0.161 | 0.094 | Mucolytic | 0.094 0.087 DBMET00338 | DBMET00338 | |
| 0.012 | 0.121 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.011 DBMET00294 | DBMET00294 | |
| 0.155 | 0.291 | 0.26 | Antibacterial | 0.26 0.168 DBMET00338 | DBMET00338 | |
| 0.097 | 0.249 | 0.162 | Succinate dehydrogenase inhibitor | 0.162 0.092 DBMET00338 | DBMET00338 | |
| 0.078 | 0.262 | 0.194 | Aldehyde oxidase inhibitor | 0.194 0.108 DBMET00338 | DBMET00338 | |
| 0.037 | 0.233 | 0.069 | Glutamate (mGluR6) antagonist | 0.069 0.041 DBMET00338 | DBMET00338 | |
| 0.029 | 0.236 | 0.074 | GABA aminotransferase inhibitor | 0.074 0.056 DBMET00338 | DBMET00338 | |
| 0.017 | 0.289 | 0.038 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.038 0.037 DBMET00338 | DBMET00338 | |
| 0.031 | 0.328 | 0.086 | HIV-1 integrase (Overall Integration) inhibitor | 0.086 0.069 DBMET00338 | DBMET00338 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |